ロード中...
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
BACKGROUND: Tamoxifen was recommended by NICE in 2013 for chemoprevention of breast cancer, but a recent survey suggested only a quarter of GPs are aware of this. We set out to measure the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets. METHODS: Tamoxifen and...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943266/ https://ncbi.nlm.nih.gov/pubmed/29681615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0065-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|